Ignyta Names Senior VP, Chemistry & Manufacturing
This article was originally published in Scrip
Ignyta, Inc., a precision oncology biotechnology company, has appointed Dr Valerie Harding to the newly created role of senior vice-president, chemistry, manufacturing, and controls. Harding joins Ignyta from Pfizer, where she held many roles including vice-president of product differentiation, vice-president of drug product design and vice-president of pharmaceutical development. Prior to Pfizer, Harding spent three years as a scientist and team leader at Boots and Company, preceded by three years as a tutor and researcher at the University of Nottingham's School of Pharmacy. Harding holds a Ph.D. in Pharmaceutical Microbiology from the University of Nottingham and a B.S. in Pharmacy from the University of London.
Register for our free email digests: